EMEA-002894-PIP01-20 - paediatric investigation plan

paclitaxel

Key facts

• Active substance:
  paclitaxel
• Therapeutic area:
  Oncology
• Decision number:
  P/0141/2021
• PIP number:
  EMEA-002894-PIP01-20
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Treatment of soft tissue sarcoma
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  14/04/2021
• Compliance check done:
  No

Decision

P/0141/2021 : EMA decision of 14 April 2021 on the granting of a product specific waiver for paclitaxel (EMEA-002894-PIP01-20)

Reference Number: EMA/188599/2021